261 related articles for article (PubMed ID: 23695644)
1. Current state of knowledge on oral anticoagulant reversal using procoagulant factors.
Nitzki-George D; Wozniak I; Caprini JA
Ann Pharmacother; 2013 Jun; 47(6):841-55. PubMed ID: 23695644
[TBL] [Abstract][Full Text] [Related]
2. Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis.
Levy JH; Connors JM; Steiner ME; Douketis J; Spyropoulos AC
Res Pract Thromb Haemost; 2020 May; 4(4):562-568. PubMed ID: 32548554
[TBL] [Abstract][Full Text] [Related]
3. The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro.
Schultz NH; Tran HTT; Bjørnsen S; Henriksson CE; Sandset PM; Holme PA
Res Pract Thromb Haemost; 2017 Jul; 1(1):49-56. PubMed ID: 30046673
[TBL] [Abstract][Full Text] [Related]
4. Direct Oral Anticoagulation in Lung Transplant Recipients.
Hage R; Bonzon J; Schuurmans MM
Exp Clin Transplant; 2024 Apr; 22(4):249-257. PubMed ID: 38742314
[TBL] [Abstract][Full Text] [Related]
5. The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis.
Fayyaz M; Abbas F; Kashif T
Cureus; 2019 May; 11(5):e4589. PubMed ID: 31309014
[TBL] [Abstract][Full Text] [Related]
6. Controversies in Stoppage of Antiplatelet and Anticoagulant Medications Prior to Oral Surgery.
Chan MH; Sun F; Malakan J
Dent Clin North Am; 2024 Jan; 68(1):21-45. PubMed ID: 37951634
[TBL] [Abstract][Full Text] [Related]
7. A small-molecule hemostatic agent for the reversal of direct oral anticoagulant-induced bleeding.
Desvages M; Borgel D; Adam F; Tu G; Jaouen S; Reperant C; Denis CV; Desmaële D; Bianchini EP
Res Pract Thromb Haemost; 2024 May; 8(4):102426. PubMed ID: 38882463
[TBL] [Abstract][Full Text] [Related]
8. Dabigatran-Associated Intracranial Hemorrhage: Literature Review and Institutional Experience.
King AE; Szarlej DK; Rincon F
Neurohospitalist; 2015 Oct; 5(4):234-44. PubMed ID: 26425251
[TBL] [Abstract][Full Text] [Related]
9. How we treat bleeding associated with direct oral anticoagulants.
Marano G; Vaglio S; Pupella S; Liumbruno GM; Franchini M
Blood Transfus; 2016 Sep; 14(5):465-73. PubMed ID: 27136433
[TBL] [Abstract][Full Text] [Related]
10. Direct Oral Anticoagulant Reversal in the Pediatric Emergency Department.
Otero J; Mazor SS; Leoni J
Pediatr Emerg Care; 2022 Nov; 38(11):621-625. PubMed ID: 36314863
[TBL] [Abstract][Full Text] [Related]
11. Updates in Anticoagulation Therapy Monitoring.
McRae HL; Militello L; Refaai MA
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33800804
[TBL] [Abstract][Full Text] [Related]
12. How I treat patients with inherited bleeding disorders who need anticoagulant therapy.
Martin K; Key NS
Blood; 2016 Jul; 128(2):178-84. PubMed ID: 27106121
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran excess: case report and review of the literature.
Sarma A; Rossi JE; Connors JM; Giugliano RP
Cardiol Ther; 2013 Jun; 2(1):111-24. PubMed ID: 25135294
[TBL] [Abstract][Full Text] [Related]
14. Bleeding with concomitant ibrutinib and oral anticoagulant therapy: A population-based cohort study.
Dhopeshwarkar N; Yang W; Hennessy S; Rhodes JM; Cuker A; Leonard CE
Am J Hematol; 2023 Mar; 98(3):E49-E52. PubMed ID: 36459586
[No Abstract] [Full Text] [Related]
15. Evaluation and treatment of gastrointestinal bleeding in patients taking anticoagulants presenting to the emergency department.
Singer AJ; Abraham NS; Ganti L; Peacock WF; Dark J; Ishaq H; Negrete A; Mount B; Neuenschwander J
Int J Emerg Med; 2024 May; 17(1):70. PubMed ID: 38822267
[TBL] [Abstract][Full Text] [Related]
16. Novel Substituted Azoloazines with Anticoagulant Activity.
Spasov AA; Fedorova OV; Rasputin NA; Ovchinnikova IG; Ishmetova RI; Ignatenko NK; Gorbunov EB; Sadykhov GAO; Kucheryavenko AF; Gaidukova KA; Sirotenko VS; Rusinov GL; Verbitskiy EV; Charushin VN
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958560
[TBL] [Abstract][Full Text] [Related]
17. Cancer unmasked by bleeding during anticoagulant therapy: when a problem may become an opportunity.
Andreotti F; Maggioni AP
Eur Heart J; 2022 Feb; 43(7):e45-e47. PubMed ID: 32268370
[No Abstract] [Full Text] [Related]
18. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
19. Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy.
Awad NI; Cocchio C
P T; 2013 Nov; 38(11):696-701. PubMed ID: 24391389
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulants and status of antidotes for the reversal of bleeding risk.
Ebright J; Mousa SA
Clin Appl Thromb Hemost; 2015 Mar; 21(2):105-14. PubMed ID: 25115762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
